QTREX Quantum awards 170K RSUs to director

QTREX Quantum Ltd. (QTEX) reported that director Amit Lior received a grant of 170,000 Restricted Share Units (RSUs) on 2026-08-28, recorded as an acquisition of Ordinary Shares at a stated price of $0.0000 per share.

Rhea-AI Filing Summary

QTREX Quantum Ltd. (QTEX) reported that director Amit Lior received a grant of 170,000 Restricted Share Units (RSUs) on 2026-08-28, recorded as an acquisition of Ordinary Shares at a stated price of $0.0000 per share. Following this equity award, Lior’s direct holdings total 231,667 Ordinary Shares.

The RSUs were granted under QTREX Quantum Ltd.’s 2019 Plan. According to the vesting schedule, 33.34% of the RSUs vest on the first anniversary date following July 1, 2026, and the remaining RSUs vest at 8.33% per quarter over the next eight quarters. The RSU grant was approved by the company’s shareholders at an Extraordinary General Meeting of Shareholders held on 2026-08-28.

Insider Trade Summary

Grant/Award: 170,000 shares

Grant/Award 1 txn

Insider Amit Lior

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	170,000	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 231,667 shares (Direct)

Footnotes (1)

1. F1. The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment"); and (ii) 8.33% of the RSUs will vest on a quarterly basis over 8 quarters (two (2) years), following the First Instalment. The grant of RSUs was approved by the Company's shareholders at an Extraordinary General Meeting of Shareholders held on August 28, 2026.

Key Figures

RSUs granted: 170,000 RSUs Stated transaction price per share: $0.0000 per share Shares owned after transaction: 231,667 Ordinary Shares +4 more

7 metrics

RSUs granted 170,000 RSUs Restricted Share Units granted to director Amit Lior on 2026-08-28

Stated transaction price per share $0.0000 per share Recorded price for the RSU-related Ordinary Shares

Shares owned after transaction 231,667 Ordinary Shares Direct holdings of Amit Lior after the award

Initial vesting portion 33.34% of RSUs Vests on the first anniversary date following July 1, 2026

Subsequent quarterly vesting 8.33% per quarter over 8 quarters Remaining RSUs vest over two years after the first instalment

Extraordinary General Meeting date August 28, 2026 Date shareholders approved the RSU grant

Plan name year 2019 Plan Equity compensation plan under which RSUs were granted

Key Terms

Restricted Share Units ("RSUs"), 2019 Plan, vest, Extraordinary General Meeting of Shareholders

4 terms

Restricted Share Units ("RSUs") financial

"The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s"

2019 Plan financial

"were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan"

vest financial

"and will vest according to the following schedule"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Extraordinary General Meeting of Shareholders regulatory

"approved by the Company's shareholders at an Extraordinary General Meeting of"

A meeting called by a company outside its regular annual meeting to address urgent or special matters that cannot wait until the next scheduled meeting. Investors attend or vote to decide on actions such as major deals, leadership changes, capital-raising, or rule changes; think of it as an emergency board meeting where shareholders have a direct say and the outcomes can quickly change a company’s strategy, ownership stakes, or financial prospects.

FAQ

What insider transaction did QTEX director Amit Lior report on this Form 4?

Director Amit Lior reported an acquisition of 170,000 Restricted Share Units (RSUs) relating to Ordinary Shares of QTREX Quantum Ltd. on 2026-08-28, as an equity award recorded at a stated price of $0.0000 per share.

How many QTEX shares does Amit Lior hold after this RSU grant?

After the reported grant, Amit Lior directly holds 231,667 Ordinary Shares of QTREX Quantum Ltd., as shown in the Form 4’s post-transaction ownership figure.

What is the vesting schedule for Amit Lior’s 170,000 QTEX RSUs?

The 170,000 RSUs vest as follows: 33.34% on the first anniversary date following July 1, 2026, and the remaining RSUs vest at 8.33% on a quarterly basis over 8 quarters (two years) after that first instalment.

Under which plan were the QTEX RSUs granted to Amit Lior?

The Restricted Share Units granted to Amit Lior were issued under QTREX Quantum Ltd.’s 2019 Plan, as described in the Form 4 footnote.

Did QTREX Quantum shareholders approve the RSU grant to Amit Lior?

Yes. The Form 4 states that the RSU grant was approved by the Company’s shareholders at an Extraordinary General Meeting of Shareholders held on August 28, 2026.

Is Amit Lior’s QTEX RSU transaction reported under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is marked false, indicating the transaction is not affirmed as being made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:07 PM Accepted by SEC EDGAR 09/01/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Amit Lior

(Last) (First) (Middle)

2 ILAN RAMON ST.

(Street)

NESS-ZIONA 7492625

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
QTREX Quantum Ltd. [ QTEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/28/2026		A		170,000(1)	A	$0	231,667	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment"); and (ii) 8.33% of the RSUs will vest on a quarterly basis over 8 quarters (two (2) years), following the First Instalment. The grant of RSUs was approved by the Company's shareholders at an Extraordinary General Meeting of Shareholders held on August 28, 2026.

	/s/ Lior Amit	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)